LONG-TERM COST-EFFECTIVENESS OF ESKETAMINE FOR THE TREATMENT OF TREATMENT-RESISTANT DEPRESSION

被引：0
|
作者：
Touchette, D. [1 ]
Boyer, N. [2 ]
Atlas, S. J. [3 ]
Agboola, F. O. [4 ]
Talon, B. [1 ]
Schultz, B. [1 ]
Kumar, V. M. [4 ]
Fazioli, K. [4 ]
Fluetsch, N. [4 ]
Rind, D. [4 ]
机构：
[1] Univ Illinois, Coll Pharm, Chicago, IL USA
[2] Univ Chicago Hosp Med, Chicago, IL USA
[3] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA
[4] Inst Clin & Econ Review, Boston, MA USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH16
引用
收藏
页码：S683 / S683
页数：1
相关论文
共 50 条
  • [41] Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C
    Sroczynski, G.
    Esteban, E.
    Conrads-Frank, A.
    Schwarzer, R.
    Muehlberger, N.
    Wright, D.
    Zeuzem, S.
    Siebert, U.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (01) : 34 - 50
  • [42] Intranasal esketamine efficacy as a treatment for treatment-resistant depression, case series
    Delgado Marmisa, C.
    Alvarez Correa, I.
    Vizcaino Herrezuelo, H.
    Eguen Recuero, L.
    Garrido Dobrito, E.
    Gayubo Moreo, L.
    Sanz-Aranguez, B.
    Delgado Tellez, L.
    Caballero Martinez, L.
    De Arce Cordon, R.
    Jimenez-Fernandez, B.
    EUROPEAN PSYCHIATRY, 2024, 67 : S692 - S692
  • [43] Examination of a case of "treatment failure" in long-term psychoanalytic psychotherapy for treatment-resistant depression
    Willemsen, Jochem
    Rost, Felicitas
    Hustinx, Marie
    Fonagy, Peter
    Taylor, David
    INTERNATIONAL JOURNAL OF PSYCHOANALYSIS, 2024, 105 (04): : 475 - 495
  • [44] Esketamine Treatment Trajectory of Patients with Treatment-Resistant Depression in the Mid and Long-Term Run: Data from REAL-ESK Study Group
    Rosso, Gianluca
    d'Andrea, Giacomo
    Barlati, Stefano
    Di Nicola, Marco
    Andriola, Ileana
    Marcatili, Matteo
    Martiadis, Vassilis
    Olivola, Miriam
    Di Mauro, Stefania
    Di Salvo, Gabriele
    De Fazio, Pasquale
    Clerici, Massimo
    Dell'Osso, Bernardo Maria
    Vita, Antonio
    Di Lorenzo, Giorgio
    Pettorruso, Mauro
    Martinotti, Giovanni
    Maina, Giuseppe
    CURRENT NEUROPHARMACOLOGY, 2025, 23 (05) : 612 - 619
  • [45] Effectiveness and Tolerability of Intranasal Esketamine in Treatment-Resistant Depression: Report of Two Clinical Cases
    Mercado-Rodriguez, A.
    Martin Requena, C.
    Cano Baena, A.
    Zorrilla Martinez, I.
    Gonzalez-Pinto Arrillaga, A.
    Mar-Barrutia, L.
    EUROPEAN PSYCHIATRY, 2023, 66 : S824 - S824
  • [46] Cost-effectiveness analysis in long-term treatment of risk factors
    Szucs, TD
    Gutzwiller, F
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1998, 128 (49) : 1958 - 1964
  • [47] Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression
    Degerlund Maldi, Kinza
    Asellus, Peter
    Myleus, Anna
    Norstrom, Fredrik
    BMC PSYCHIATRY, 2021, 21 (01)
  • [48] COST-EFFECTIVENESS OF CLOZAPINE FOR TREATMENT-RESISTANT SCHIZOPHRENIC-PATIENTS
    REVICKI, DA
    LUCE, BR
    WESCHLER, JM
    BROWN, RE
    ADLER, MA
    HOSPITAL AND COMMUNITY PSYCHIATRY, 1990, 41 (08): : 850 - 854
  • [49] Cost-effectiveness of cognitive behavioural therapy for treatment-resistant depression: challenges and solutions conducting an economic evaluation of the long-term follow-up of the cobalt trial
    Kirsty Garfield
    Laura Thomas
    Tim Peters
    Nicola Wiles
    Sandra Hollinghurst
    Trials, 16
  • [50] Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression
    Kinza Degerlund Maldi
    Peter Asellus
    Anna Myléus
    Fredrik Norström
    BMC Psychiatry, 21
12345